These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7156025)

  • 1. Ultrasonic placental localization in relation to spontaneous abortion after mid-trimester amniocentesis.
    Hill JA; Reindollar RH; McDonough PG
    Prenat Diagn; 1982 Oct; 2(4):289-95. PubMed ID: 7156025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous abortion following mid-trimester amniocentesis. Clinical significance of placental perforation and blood-stained amniotic fluid.
    Kappel B; Nielsen J; Brogaard Hansen K; Mikkelsen M; Therkelsen AJ
    Br J Obstet Gynaecol; 1987 Jan; 94(1):50-4. PubMed ID: 3814555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic mid trimester amniocentesis: how safe?
    Seeds JW
    Am J Obstet Gynecol; 2004 Aug; 191(2):607-15. PubMed ID: 15343248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of spontaneous abortion after amniocentesis: influence of placental localization and past obstetric and gynecologic history.
    Andreasen E; Kristoffersen K
    Am J Perinatol; 1989 Apr; 6(2):268-73. PubMed ID: 2653338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplacental needle passage and other risk-factors associated with second trimester amniocentesis.
    Marthin T; Liedgren S; Hammar M
    Acta Obstet Gynecol Scand; 1997 Sep; 76(8):728-32. PubMed ID: 9348248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technical factors in early amniocentesis predict adverse outcome. Results of the Canadian Early (EA) versus Mid-trimester (MA) Amniocentesis Trial.
    Johnson JM; Wilson RD; Singer J; Winsor E; Harman C; Armson BA; Benzie R; Dansereau J; Ho MF; Mohide P; Natale R; Okun N
    Prenat Diagn; 1999 Aug; 19(8):732-8. PubMed ID: 10451517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risks of midtrimester amniocentesis; assessment in 3000 pregnancies.
    Leschot NJ; Verjaal M; Treffers PE
    Br J Obstet Gynaecol; 1985 Aug; 92(8):804-7. PubMed ID: 4027202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk assessment of amniocentesis between 11 and 15 weeks: comparison to later amniocentesis controls.
    Crandall BF; Kulch P; Tabsh K
    Prenat Diagn; 1994 Oct; 14(10):913-9. PubMed ID: 7534922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasonography-guided early amniocentesis in singleton pregnancies.
    Hanson FW; Happ RL; Tennant FR; Hune S; Peterson AG
    Am J Obstet Gynecol; 1990 Jun; 162(6):1376-81; discussion 1381-3. PubMed ID: 2193512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy loss rates after midtrimester amniocentesis.
    Wapner RJ; Evans MI; Platt LD
    Obstet Gynecol; 2007 Mar; 109(3):780; author reply 780-1. PubMed ID: 17329536
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic amniocentesis: impact of placental position upon the risk of pregnancy loss.
    Crane JP; Kopta MM
    Am J Obstet Gynecol; 1984 Dec; 150(7):813-6. PubMed ID: 6391172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy loss rates after midtrimester amniocentesis.
    Nicolaides K
    Obstet Gynecol; 2007 Mar; 109(3):780; author reply 780-1. PubMed ID: 17329535
    [No Abstract]   [Full Text] [Related]  

  • 13. Amniocentesis-related adverse outcomes according to placental location and risk factors for fetal loss after midtrimester amniocentesis.
    Kalogiannidis I; Prapa S; Dagklis T; Karkanaki A; Petousis S; Prapas Y; Prapas N
    Clin Exp Obstet Gynecol; 2011; 38(3):239-42. PubMed ID: 21995155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors predisposing to fetal loss following a second trimester amniocentesis.
    Papantoniou NE; Daskalakis GJ; Tziotis JG; Kitmirides SJ; Mesogitis SA; Antsaklis AJ
    BJOG; 2001 Oct; 108(10):1053-6. PubMed ID: 11702837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal loss following second trimester amniocentesis. Who is at greater risk? How to counsel pregnant women?
    Theodora M; Antsaklis A; Antsaklis P; Blanas K; Daskalakis G; Sindos M; Mesogitis S; Papantoniou N
    J Matern Fetal Neonatal Med; 2016; 29(4):590-5. PubMed ID: 25747948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisiting the fetal loss rate after second-trimester genetic amniocentesis: a single center's 16-year experience.
    Odibo AO; Gray DL; Dicke JM; Stamilio DM; Macones GA; Crane JP
    Obstet Gynecol; 2008 Mar; 111(3):589-95. PubMed ID: 18310360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for procedure-related fetal losses after mid-trimester genetic amniocentesis.
    Kong CW; Leung TN; Leung TY; Chan LW; Sahota DS; Fung TY; Lau TK
    Prenat Diagn; 2006 Oct; 26(10):925-30. PubMed ID: 16838383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous abortion after amniocentesis in women with a history of spontaneous abortion.
    Esrig SM; Leonardi DE
    Prenat Diagn; 1985; 5(5):321-8. PubMed ID: 4070171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal-maternal bleeding associated with genetic amniocentesis.
    Mennuti MT; Brummond W; Crombleholme WR; Schwarz RH; Arvan DA
    Obstet Gynecol; 1980 Jan; 55(1):48-54. PubMed ID: 6153239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mid-trimester amniocentesis and antibiotic prophylaxis.
    Gramellini D; Fieni S; Casilla G; Raboni S; Nardelli GB
    Prenat Diagn; 2007 Oct; 27(10):956-9. PubMed ID: 17607664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.